Parkinson´s Disease, Aerobic Exercise and Photobiomodulation
PDAERPBM
1 other identifier
interventional
72
1 country
1
Brief Summary
The aim of the present study was to assess the effects of a combined therapy of aerobic exercise and transcranial photobiomodulation upon the cardinal motor sympomts of Parkinson´s disease of a group of Parkinson´s disease patients. It was hypothesized that aerobic exercise and transcranial photobiomodulation would yield significant benefits in the cardinal motor sympomts of the illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Jan 2021
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2021
CompletedFirst Submitted
Initial submission to the registry
November 28, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedDecember 6, 2024
December 1, 2024
3.5 years
November 28, 2021
December 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
MDS-UPDRS
The motor portion of the Movement Disorder Society-Unified Parkinson´s (MDS-UPDRS, the minimum and maximum values are 0 and 72, respectively and the higher score, the worse patient condition)
6 months
Secondary Outcomes (5)
DASH
6 months
Static posturography
6 months
TMWT
6 months
TUG
6 months
Grip strength
6 months
Study Arms (4)
Intervention aerobic (IAER)
EXPERIMENTALPatients assigned to the IAER participated in fourty-eigth aerobic exercise therapy sessions over the course of six months.
Intervention photobiomodulation (IPBM)
EXPERIMENTALPatients assigned to the IPBM participated in fourty-eigth transcraneal photobiomodulation (PBM) theraphy sessions, using a therapeutic laser console, over the course of six months.
Intervention aerobic and photobiomodulation (IAER+PBM9
EXPERIMENTALPatients assigned to the IAER+PBM participated in the aerobic exercise therapy and the PBM one at the same time, during six months.
Control (CO)
NO INTERVENTIONPatients assigned to the control (CO) did not participated in any kind of therapy, they just followed their usual weekly routine during six months
Interventions
Cycling at the aerobic intensity
Photons therapy
Eligibility Criteria
You may qualify if:
- Diagnosis with idiopathic PD and rated 1-2 on the Hoehn and Yahr Scale.
- No type of dementia as assessed by the mini-mental state examination.
- Able to stand for 2 min without assistance.
- Able to walk 10 m without assistance.
You may not qualify if:
- Individuals were excluded if they suffered a neurological disease other than PD, if the subject has an implant of any kind in the head (e.g., stent, clipped aneurysm, embolized arteriovenous malformation, implantable shunt - Hakim valve) or if they did not meet the eligibility criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physical Education and Sport, University of León
León, Castille and León, 24071, Spain
Related Publications (1)
Santos L, Burtscher J, de Taboada L. Parkinson's disease, aerobic exercise and photobiomodulation: a randomised controlled trial. J Neural Transm (Vienna). 2025 Oct 31. doi: 10.1007/s00702-025-03050-7. Online ahead of print.
PMID: 41171380DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 28, 2021
First Posted
December 10, 2021
Study Start
January 10, 2021
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
December 6, 2024
Record last verified: 2024-12